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We report a case of a 46-year old man who presented with spontaneous bright red blood per mouth for
several months. The patient had history of aortic coarctation repair at age 17. Endoscopy and naso-
pharyngeoscopy revealed no source of bleeding. Computed tomography scan revealed the presence of
thoracic aortic pseudoaneurysm with the formation of an aortobronchial ﬁstula (ABF). This case illus-
trates the high index of suspicion for ABF in the case of hemoptysis or hematemesis with prior history of
coarctation repair. Furthermore, we discuss the role of thoracic endovascular aneurysm repair (TEVAR) as
the standard of repair over open surgery.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case presentation
The patient is a 46 year-old man who presented to our institu-
tion with bright red blood per mouth for several months. Initially it
was felt the bleeding was from a GI source and upper endoscopy
and nasopharyngeoscopy were performed with no signiﬁcant
ﬁndings. These episodes occurred sporadically with periods of
weeks without any bleeding. On several occasions, he lost con-
sciousness and was transfused in hospital. He had no history of
infection or fever.
The patient reported a past repair of congenital coarctation of
the aorta by left thoracotomy at age 17. Surgical history also
included mechanical aortic valve replacement at age 25 for a
bicuspid valve requiring anticoagulation (Warfarin). Other signiﬁ-
cant medical history included cardio-embolic stroke with transient
vision impairment, obesity and poorly controlled type 2 diabetes.
Social history included social smoking in teenage years and mini-
mal alcohol intake.
Further investigations included a non-enhanced computed to-
mography (CT) scan revealing a mass in the left lower lobe invading
the descending aorta consistent with a lung neoplasm. Prior to a
bronchoscopy, a vascular surgery consultation recommended anampus, 1053 Carling Avenue,
Ltd. This is an open access article uenhanced CT, which revealed a pseudoaneurysm of the aorta sur-
rounded by lung tissue consistent with ﬁndings of an aortobron-
chial ﬁstula (ABF) (Fig. 1). This pseudoaneurysm was likely
secondary to previous aortic coarctation repair. The bronchoscopy
was deferred.
The patient was started on broad-spectrum antibiotics (IV Pip-
tazo 3.375 g q 6 h) for 2 days prior to operative repair of this ﬁstula.
Endovascular treatment was chosen. The thoracic pseudoaneurysm
was repaired using the Cook Zenith TX2 32-80 graft. The graft was
positioned under direct ﬂuoroscopy such that it covered the aorta
above the pseudoaneurysm by 4 cm, and distally by 2 cm (Fig. 2).
There were no intra-operative issues and the patient recovered
well.
Post-operatively the patient was kept on IV Piptazo for 2 weeks.
He was then switched to Amox-Claculin 875 mg po BID to prevent
any infection due to communication between the lung parenchyma
and the endovascular stent graft that was used to exclude the ABF.
Furthermore, he is kept on Warfarin 6 mg daily anticoagulation for
his mechanical heart valve. The patient will need lifelong surveil-
lance to prevent recurrence, including regular CT scan follow-up to
ensure no endoleak or migration of the endovascular prosthesis
(Fig. 3).
2. Discussion
ABF is a rare but potentially life-threating cause of hemoptysis if
not adequately treated [1]. Most ABFs originate from a descendingnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Preoperative computed tomography (CT) images of the chest consistent with aortobronchial ﬁstula (ABF). (A) Unenhanced CT showing mass initially thought to be a
neoplasm (white arrow). (B) Enhanced CT showing ABF (yellow arrow).
Fig. 2. Intra-operative angiogram during thoracic endovascular aneurysm repair
(TEVAR) illustrating successful exclusion of the aortobronchial ﬁstula.
Fig. 3. CT image of the chest showing thoracic endovascular aneurysm repair suc-
cessfully excluding the aortobronchial ﬁstula. (White arrow e endovascular stent
graft).
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erosion of the lung parenchyma or tracheobronchial tree; this al-
lows blood to travel from the aorta into the lung, manifesting as
frank hemoptysis. The aneurysm can have numerous etiologies
including tuberculosis, syphilis, fungal infections, trauma and
atherosclerosis, mainly seen in elderly patients [6]. In younger pa-
tients, ABF is more frequently can be secondary to surgical repair of
congenital heart defects, and aortic coarctation repair [1,6]). Several
factors can lead to ﬁstula. In the cases where surgical intervention
involves the implantation of prosthesis, as is the case in aortic
coarctation correction, the aneurysm or pseudoaneurysm can form
in the proximal or distal suture lines of the prosthesis. Once formed,
the continuous pressure of blood against the weakened vascular
wall leads to damage of the aorta and subsequent lung parenchyma
- usually of the left lung - resulting in the formation of a commu-
nication between the two structures. Furthermore, the foreignmaterial can become attached to the lung tissue and cause
inﬂammation [2].
The case described here illustrates the high index of suspicion
and appropriate investigations required for any bleeding that may
be considered hemoptysis or hematemesis with a case of prior
aortic coarctation repair. Hemoptysis is the most frequent clinical
manifestation of ABF and can appear between 3 weeks and 25 years
after surgery [4]. Episodes are usually recurrent and self-limited, as
was the case with our patient. They tend to increase in severity,
leading to massive hemoptysis. Temporary obstruction of the ﬁs-
tula by blood clots is thought to be the reason for this intermittency
in hemoptysis presentation. Chest pain may also be present,
occurring in 45% of cases of ABF [1], but did not occur in our patient.
Due to the non-speciﬁc nature of hemoptysis, diagnosis of ABF is
often difﬁcult. Chest x-rays tend to be either normal, or show
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in only 16% of cases [5]. CT is the most appropriate diagnostic tool.
This imaging can reveal, in addition to the aneurysm itself, peri-
aortic hematoma, mural thrombus and contrast extravasation to
the lung parenchyma. When ABF is suspected, bronchoscopy must
be used with caution, particularly when there is abundant he-
moptysis; the scope may cause mobilization of thrombi in the ﬁs-
tula, which may lead to massive hemorrhage [2].
Surgical intervention is the treatment of choice in most patients
and can be performed with relatively low risk of mortality. The
main goals of surgical repair are maintenance of distal perfusion
and repair of aortic and pulmonary defects. Classically, open sur-
gical approach was considered the mainstay treatment, with either
direct suture or patch closure of the aortic defect, anatomic
reconstruction, debridement and drainage. However, this approach
is reported to carry an operative mortality rate of 20% [5].
Thoracic endovascular aneurysm repair (TEVAR) is an advanta-
geous alternative to open repair, as it allows prompt exclusion of
thoracic aortic ﬁstulas and control of hemorrhage while being
minimally invasive. Larger case series of TEVAR for ABF are prom-
ising, reporting 100% operative survival and a mortality of 0%e25%
at 3 years post-operatively [7,8]. This evidence changes the man-
agement algorithm for the ABF diagnosis and now TEVAR should be
considered the standard of care.
Prosthetic graft infection is a signiﬁcant concern following
repair of ABF. During open surgical, antibiotic irrigation is
employed intra-operatively, and in some cases the prosthetic graft
is soaked in antibiotic solution prior to implantation [3].
Conversely, TEVAR alone does not allow debridement of the
potentially contaminated thoracic cavity. That being said, the risk of
infection after endograft deployment appears to be minimal. It has
been suggested that this low infection rate can be attributed to the
fact that there is little tissue associated with graft deployment, as
opposed to open surgical repairs, thus the pseudoaneurysmal
cavity is likely to become contaminated and subsequently infected.
Furthermore, the excluded aneurysmal cavity may still remainviable after endograft placement from small collateral blood vessels
that were not disrupted during repair, thus preventing infection [8].
Our patient had recurrent episodes of hemoptysis for several
months prior to a contrast-enhanced CT scan revealing the diag-
nosis. While the thoracic endograft did successfully exclude the
pseodoaneurysm, the delayed diagnosis may increase the chance of
endograft infection. Therefore, the current decision is to place the
patient on oral antibiotic indeﬁnitely to reduce or suppress the risk
of graft infection. Current evaluation at 1 year post-operatively
shows no sign of infection.
In summary, the possibility of aortic pseudoaneurysm and ABF
should be considered in the differential diagnosis of hemoptysis in
a patient with previous history of coarctation repair. TEVAR repair
has been shown to be safe and well tolerated, thus should be
considered the standard of care. Long-term surveillance and anti-
biotic prophylaxis of endograft infection should be considered.
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